Contrasting Firefly Neuroscience (NASDAQ:AIFF) and Aurora Innovation (NASDAQ:AUR)

Firefly Neuroscience (NASDAQ:AIFF) and Aurora Innovation (NASDAQ:AUR) are both business services companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, dividends, analyst recommendations, institutional ownership, valuation, risk and earnings.

Earnings and Valuation

This table compares Firefly Neuroscience and Aurora Innovation”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Firefly Neuroscience	$783,000.00	13.39	-$10.46 million	($2.09)	-0.35
Aurora Innovation	N/A	N/A	-$748.00 million	($0.45)	-9.51

Firefly Neuroscience has higher revenue and earnings than Aurora Innovation. Aurora Innovation is trading at a lower price-to-earnings ratio than Firefly Neuroscience, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Firefly Neuroscience and Aurora Innovation’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Firefly Neuroscience	-2,705.88%	-319.00%	-191.27%
Aurora Innovation	N/A	-40.44%	-35.96%

Risk and Volatility

Firefly Neuroscience has a beta of 1.91, indicating that its stock price is 91% more volatile than the S&P 500. Comparatively, Aurora Innovation has a beta of 2.47, indicating that its stock price is 147% more volatile than the S&P 500.

Institutional and Insider Ownership

5.0% of Firefly Neuroscience shares are owned by institutional investors. Comparatively, 44.7% of Aurora Innovation shares are owned by institutional investors. 6.4% of Firefly Neuroscience shares are owned by company insiders. Comparatively, 11.9% of Aurora Innovation shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Analyst Recommendations

This is a summary of recent recommendations for Firefly Neuroscience and Aurora Innovation, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Firefly Neuroscience	1	0	0	0	1.00
Aurora Innovation	2	3	5	0	2.30

Aurora Innovation has a consensus target price of $10.06, suggesting a potential upside of 135.11%. Given Aurora Innovation’s stronger consensus rating and higher possible upside, analysts plainly believe Aurora Innovation is more favorable than Firefly Neuroscience.

Summary

Aurora Innovation beats Firefly Neuroscience on 10 of the 13 factors compared between the two stocks.

About Firefly Neuroscience

Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.

About Aurora Innovation

Aurora Innovation, Inc. operates as a self-driving technology company in the United States. It focuses on developing Aurora Driver, a platform that brings a suite of self-driving hardware, software, and data services together to adapt and interoperate vehicles. The company was founded in 2017 and is headquartered in Pittsburgh, Pennsylvania.